fashion -WSS

fashion

author：hotspot 2025-10-01 13:59:04 - browse：5998

Stock exchange — Drew Angerer/Getty Images

Sage Therapeutics said Monday that it may need to reduce costs, including through employee layoffs, following the Food and Drug Administration’s denial of its rapid-acting drug for major depressive disorder.

On Friday, the agency granted market clearance for the drug, called Zurzuvae, to treat women with postpartum depression, a smaller commercial market. Sage failed to convince regulators to also approve the drug for depression, a broader condition.

“We don’t agree with the FDA review,” Sage CEO Barry Greene said during an earnings call, a point he made repeatedly. “We are evaluating the [FDA’s response letter] and as soon as we can provide more clarity, we will, on what the next steps are.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： Research misconduct: Proposed new rules face resistance

explore

WSS

UnitedHealth CEO's Medicaid comments send insurer stocks diving

Why doctors need education on FDA device approval process

FDA clears AI tool for detecting skin cancer

FDA approves Moderna’s RSV vaccine, its second licensed product

Congress needs to close a vaccine

Francis Collins on trust in science and how Covid communications failed

leisure time

fashion

Wikipedia

How one medical school became remarkably diverse

Fight over Supreme Court dialysis ruling puts kidney patients at risk

Dobbs anniversary: the lost opportunity of abortion as health care

Copay coupons to count toward deductibles, after Biden court move

Supreme Court strikes down use of affirmative action

Test for long Covid? Researchers find new clue in blood samples

Medicare proposal to cover medical devices draws a mixed reaction

NIH director takes cautious approach to Biden drug pricing priority

Anesthesiologist group: stop taking Ozempic before surgery

Prior authorization will have to move faster under new Biden rule

Wikipedia

Francis Collins on trust in science and how Covid communications failed

The surgeon had a dilemma only a Nazi medical text could resolve

A new initiative will help leaders fight the next pandemic

STAT wants to know your pick for a great summer read or listen

Why doctors need education on FDA device approval process

My yearlong odyssey to get my son’s ADHD medication covered

focus

explore

entertainment

leisure time